Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

iRhythm Holdings (IRTC) Research & Development (2016 - 2025)

Historic Research & Development for iRhythm Holdings (IRTC) over the last 11 years, with Q3 2025 value amounting to $21.0 million.

  • iRhythm Holdings' Research & Development rose 3401.94% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.6 million, marking a year-over-year increase of 2190.61%. This contributed to the annual value of $71.5 million for FY2024, which is 1861.6% up from last year.
  • As of Q3 2025, iRhythm Holdings' Research & Development stood at $21.0 million, which was up 3401.94% from $21.0 million recorded in Q2 2025.
  • iRhythm Holdings' 5-year Research & Development high stood at $21.5 million for Q1 2025, and its period low was $8.5 million during Q1 2021.
  • For the 5-year period, iRhythm Holdings' Research & Development averaged around $14.8 million, with its median value being $14.8 million (2023).
  • As far as peak fluctuations go, iRhythm Holdings' Research & Development crashed by 2340.93% in 2021, and later skyrocketed by 4396.43% in 2024.
  • iRhythm Holdings' Research & Development (Quarter) stood at $11.9 million in 2021, then rose by 6.78% to $12.7 million in 2022, then rose by 21.63% to $15.4 million in 2023, then increased by 23.77% to $19.1 million in 2024, then grew by 10.23% to $21.0 million in 2025.
  • Its last three reported values are $21.0 million in Q3 2025, $21.0 million for Q2 2025, and $21.5 million during Q1 2025.